We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Blood Test Guides Treatment of Heart Failure

By HospiMedica staff writers
Posted on 21 Nov 2002
A study has shown that a simple blood test can predict which patients with heart failure can easily be started on an established treatment to improve survival.

The study involved 84 patients referred to a heart failure clinic. More...
Beta-blockers were started in all patients at a low dose, which was gradually increased over a period of eight weeks. During the study, all patients were given a blood test that measured NT pro-BNP, a substance produced by the heart when it is failing. The test accurately predicted which patients could not safely be started on the beta-blockers. In this study, almost 90% of the patients were able to take beta-blockers. The remaining 10% had unacceptable side effects.

Beta-blockers have been shown to improve symptoms of heart failure, such as breathlessness and ankle swelling, and to prolong survival. The study, conducted by researchers at the Western Infirmary of the University of Glasgow (UK), was presented at the annual congress of the European Society of Cardiology in Berlin (Germany).




Related Links:
U. of Glasgow

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Radiofrequency Generator
GX1
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.